Odds
Yes82%
Market details
Status
resolved
Positions
2
Volume
101 cr
Locks
Jan 30, 2026
Updated
Dec 20, 2025, 03:30 PM
Rules summary
Resolves YES if Zepbound (tirzepatide) US WAC annualized price is < $11,500/year as of Dec 31, 2026. Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
Market context
Example obesity pricing market; keeps tags aligned for better filtering.
People are also buying
BrowseCommunity vote50% Yes · 0 votes
VoteVoting closed